Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
Recruiting · NCT02347111 · Registry updated 2025-08-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Recruiting | Phase 4 | 2025-08-24 | NCT02347111 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medtronic | 116 |
| University of Illinois at Chicago | 211 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Advocate Christ Medical Center | Oak Lawn | United States | 26 |
| Jesse Brown VA Medical Center | Chicago | United States | 5 |
| Rush University Medical Center | Chicago | United States | 283 |
| University of Illinois at Chicago | Chicago | United States | 85 |